# Monte Rosa (GLUE) — Overview

GLUE · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/glue

## Price

Last close $10.12 on Oct 15, 2026. 52-week range $9.35 – $25.31.

## Company profile

Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. The company has three programs in clinical development: MRT-6160, a VAV1-directed MGD for immune-mediated diseases; MRT-8102, a NEK7-directed MGD for inflammatory diseases driven by IL-6, and the NLRP3 inflammasome; and MRT-2359, a GSPT1-directed MGD for metastatic castration resistant prostate cancer (mCRPC).

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $28.7M |
| Revenue (quarter) | $9.0M |
| Revenue growth (year over year) | -61.33% |
| Gross profit (trailing twelve months) | $28.7M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$161.1M |
| Net income (quarter) | −$43.4M |
| Net income growth (year over year) | -252.96% |
| Net margin | -560.85% |
| Return on equity | -42.66% |
| EPS (trailing twelve months) | −$1.75 |
| Book value per share | $5.72 |
| P/E (trailing twelve months) | — |
| Price to book | 1.8 |
| Debt to assets | 29.50% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Monte Rosa (GLUE) profitable?

No. Monte Rosa reported a net loss of $161.1M over the trailing twelve months.

### How much revenue does Monte Rosa (GLUE) make?

Monte Rosa generated $28.7M in revenue over the trailing twelve months, down 61.33% year over year.

### How do I buy stock in Monte Rosa (GLUE)?

GLUE trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).